SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-19-010251
Filing Date
2019-05-16
Accepted
2019-05-16 16:36:43
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dffn20190514_s3.htm S-3 393548
2 EXHIBIT 4.1 ex_145198.htm EX-4.1 1529
3 EXHIBIT 4.3 ex_144952.htm EX-4.3 319030
4 EXHIBIT 5.1 ex_144951.htm EX-5.1 30085
5 EXHIBIT 23.1 ex_145199.htm EX-23.1 4004
6 a1.jpg GRAPHIC 10029
7 a2.jpg GRAPHIC 12367
8 dffn20190514_s3img003.gif GRAPHIC 40946
9 dffn20190514_s3img004.gif GRAPHIC 41077
10 ex01.jpg GRAPHIC 219727
11 ex02.jpg GRAPHIC 179657
12 logox.jpg GRAPHIC 13617
13 s3img002.jpg GRAPHIC 43900
  Complete submission text file 0001437749-19-010251.txt   1512677
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231541 | Film No.: 19832812
SIC: 2834 Pharmaceutical Preparations